Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2023 Mar 8;40(4):735–743. doi: 10.1007/s10815-023-02767-2

Vitamin D and in vitro fertilization: a systematic review

Ana Berquó Peleja Eller 1,✉, Dani Ejzenberg 1, Pedro Augusto Araújo Monteleone 1, José Maria Soares Jr 1, Edmund Chada Baracat 1
PMCID: PMC10224880  PMID: 36884205

Abstract

Purpose

Vitamin D (VD) action on calcium is well known, but its other properties, particularly in the human reproductive system, are not completely understood. This review aims at assessing the relationship between serum VD levels and IVF results.

Methods

A systematic review was carried out using MEDLINE, EMBASE, LILACS, Google scholar, the CAPES journal portal, and the Cochrane Library, as well as the descriptors “vitamin D” and “fertilization in vitro.” The review was conducted by two authors following the PRISMA recommendations between September 2021 and February 2022.

Results

Eighteen articles were selected. Five of them showed a positive correlation between serum VD levels and IVF results, 12 lacked any association, and 1 exhibited a negative correlation. The 3 studies that assessed VD in the follicular fluid found a positive correlation between the serum and follicular levels. Non-Hispanic White patients seemed to suffer the consequence of vitamin D deficiency more than Asian patients. In one study alone in the VD-deficient group, there was a larger number of natural killer (NK) cells, B cells, a greater proportion of helper T cells/cytotoxic T cells (Th/Tc), and an association with a smaller number of mature oocytes.

Conclusion

The association between serum VD levels and the post-IVF pregnancy rate is uncertain. However, VD levels might be more relevant in the White than in the Asian ethnicity and in the number of aspiration follicles, and they could act in the immune system having an impact both on embryo implantation and on pregnancy.

Keywords: Vitamin D, Fertilization in vitro, Human reproduction, Infertility

Introduction

Vitamin D (VD) is a steroid hormone obtained from food and supplements. After sun exposure, it is found in its D2 (ergocalciferol) and D3 (cholecalciferol) forms. It is converted into 25-hydroxyvitamin D through a hydroxylation process in the liver and into 1,25-dihydroxyvitamin D in the kidneys. The latter is the active form of the vitamin. The main VD action that is known consists of the regulation of calcium metabolism; however, the VD receptor is present in several tissues, such as the prostate, breasts, immune system cells, pancreatic beta cells, parathyroid gland cells, placenta, brain, and endometrium, among others. This is evidence of the great diversity of the possible effects of 1,25-dihydroxyvitamin D in the body [1, 2]. However, the most stable and assessable form in the circulation is the 25-OH- vitamin D3 form [1, 2].

The presence of VD receptors in reproductive organs and tissues in men and women is suggestive of a potential role or interference in the regulation of the reproductive process. In women and in animal models, the receptors are expressed in the ovaries, the placenta, and the endometrium; the gene expression of the VD receptor varies according to the menstrual cycle phase as well as to the pregnancy phase [3–5]. VD may participate in steroidogenesis by acting synergistically with insulin in estrogen and androgen production in the ovaries as evidenced by ovarian cell culture [5]. In men, such receptors have been detected in the smooth muscle of the genital tract, in testicular tissue, and in sperm [6, 7].

Animal studies have shown that VD deficiency decreases fertility and successful mating. Rat studies with compromised VD receptor expression showed harmed folliculogenesis, uterine hypoplasia, infertility, and pregnancy complications [8–10]. These findings, however, have not been confirmed in humans.

In the last few years, the relationship between VD and fertility has been targeted by many studies. However, specialists diverge about the role of VD in vitro fertilization (IVF). Studies have failed to prove the influence of VD on human reproduction, or they have used inadequate methods to evaluate the association. Hence, a critical assessment of the works in the literature may show the real impact of VD levels on the results of in IVF. This is the reason we proposed to undertake a systematic review of the association between VD and IVF.

Methods

A systematic review of published articles relevant to our theme was conducted and submitted to PROSPERO for registration. The review followed the PRISMA recommendations [11].

The search was carried out between September 2021 and February 2022 employing the following descriptors: “fertilization in vitro” or “assisted reproductive techniques” and “vitamin D.” The databases used for the search were MEDLINE, EMBASE, LILACS, Google Scholar, the CAPES journal portal, and the Cochrane Library. After the titles and abstracts of the retrieved articles were read, duplicates were excluded, along with the articles that did not address the topic, whose clinical trials were not randomized and double-blinded, or in which oral VD was administered concomitant with other medications. Only cohort, case-control, and clinical trial studies were included in the review.

The PECO strategy was used to search for and select works [12]. The search aimed for articles with (P—population of interest) women who underwent in vitro fertilization and were deficient in vitamin D (E—exposure) compared to those who were not vitamin D deficient (C—comparator or control) and with outcomes (O—outcome) of IVF (biochemical pregnancy, clinical pregnancy, or anembryonic pregnancy).

Articles were considered if published in the previous 12 years, that is, when they first started to be published in the databases, and if they were in English, Portuguese, or French.

Two authors read the titles, abstracts, and texts. When there was a need for a tiebreaker, a third author was requested.

Given the heterogeneity of the study designs and interventions, a meta-analysis could not be performed.

The Newcastle-Ottawa scale was utilized for the articles with cohorts to assess the quality of the studies. The scale was designed to evaluate cohort and case-control studies and to compare studies in the context of a systematic review. The studies are assessed within the framework of categories as follows: patient selection, comparability of study groups, methods for outcome evaluation (cohort studies), proof of exposure (case-control studies), and adequate follow-up [12].

Results

A search in the databases yielded 643 articles. After the exclusion of the duplicates, 300 remained. A review of titles and abstracts eliminated 232 more articles that fell outside the research scope. Thirty-nine additional studies were cast out for not meeting the study type criteria. The 29 remaining articles were fully read, but 10 of them were excluded for not containing groups with VD sufficiency or deficiency (Fig. 1).

Fig. 1.

Fig. 1

Flowchart of study selection

Of the 19 articles included in the systematic review, 10 were prospective cohort studies, 6 were retrospective cohort studies, and 3 were clinical trials. The number of participants in the systematic review amounted to 5402. A summary of the articles is displayed in Table 1.

Table 1.

Characteristics of the systematic review studies

Studies Country Type of study Duration (months) N Collection time/supplementation Grouping criteria for VD Assessed outcomes Main results Confounding factors
Rudick et al., 2012 USA Cohort retrospective 44 188 1 day after trigger <20 ng/mL; 20–30; ≥30 suficiency

Clinical pregnancy (CP)

Live births (LB)

Implantation rate (IR)

Vitamin D (VD) deficiency reduces pregnancy rate in Nonhispanic white women but not in Asian women Sample size, infertility causes
Garbedian et al., 2013 Canada Cohort prospective 8 173 1 week before oocyte collection < 30.05 ng/mL; ≥30.05ng/mL

CP

Ovarian reserve

IR

Higher pregnancy rate in the group with VD sufficiency Sample size, infertility causes, embryo quality
Fabris et al., 2014 Spain Cohort retrospective 7 267 2 weeks after hormone therapy <20 ng/mL; 20–30 ng/mL; >30 ng/mL

CP

Ongoing pregnancy (OP)

TI

No correlation with patients who were receptors of egg donation Body mass index (BMI)
Firouzabadi et al., 2014 Iran Cohort prospective 13 221 Oocyte collection day <10 ng/mL; 10–29 ng/mL; 30–100 ng/mL

CP

Fertilization rate (FR)

IR

No correlation with serum or follicular VD levels Sample size
Paffoni et al., 2014 Italy Cohort prospective 12 335 Before stimulation <20 ng/mL; ≥20 ng/mL

CP

FR

IR

Higher pregnancy rate in the VD-nondeficient group Race, BMI
Polyzos et al., 2014 Belgium Cohort retrospective 15 368 Trigger day <20 ng/mL; ≥20ng/mL

Biochemical pregnancy (BP)

CP

LB

FR

Lower CP rate in the VD-deficient group (single transfer of blastocysts) Embryo characteristics
Rudick et al., 2014 USA Cohort retrospective 48 99 Beginning of downregulation <20 ng/mL; 20–30 ng/mL; >30 ng/mL

CP

LV

FR

VD<30 associated with lower pregnancy rates in egg donation receptors Race, donor
Franasiak et al., 2015 USA Cohort retrospective 13 517 Trigger day <20 ng/mL; 20–30 ng/mL; >30 ng/mL

Not pregnant

Chemical pregnancy loss

Clinical pregnancy loss

OP

No correlation/only euploid embryos Race, age, pregnancy outcomes
Trably et al., 2015 France Cohort prospective 5 198 Before blockage <20ng/mL; ≥20 ng/mL

BP

OP

Miscarriage

No correlation Infertility causes, BMI
Neville et al., 2016 Ireland Cohort prospective 3 M75 and F64 Oocyte collection day <12ng/mL; 12–20 ng/mL; >20 ng/mL

OP

BP

Ovarian reserve

No correlation between males and females Race, infertility causes, exogenous VD use, sample size, season
van de Vijver et al., 2016 Belgium Cohort prospective 12 280 Embryo transfer day <20 ng/mL; ≥20 ng/mL

BP

CP

LB

No correlation Race (Caucasian)
Banker et al., 2017 India Cohort prospective 3 291 Receptor: endometrial lining >= 7mm/ Donor: beginning of the antagonist <20 ng/mL; 20–30 ng/mL; >30 ng/mL

BP

CP

Miscarriage

IR

OP

No statistically significant correlation Infertility causes, VD consumption
Fabris et al., 2017 Spain Cohort retrospective 11 851 Not reported ≥20 ng/mL; 20–30 ng/mL; >30 ng/mL

OP

BP

Miscarriage

Ovarian reserve

IR

No correlation BMI (higher in the VD deficient), age, race (95% Caucasian)
Ciepiela et al., 2018 Poland Cohort prospective 21 198 Oocyte collection day <20 ng/ml; ≥20 ng/ml

BP

CP

LB

BP

Miscarriage

FR

VD deficiency related to a higher live birth rate Race (Caucasian), only main follicle
Wu et al., 2018 China Cohort prospective 8 180 Oocyte collection day ≥20 ng/mL; >20 ng/mL

BP

CP

LB

Miscarriage

FR

IR

No correlation with pregnancy rate Race, infertility causes, group follow-up
Abedi et al., 2019 Iran Clinical trial 4 85 Before trial and 6-8 weeks after treatment <30ng/mL

FR

BP

CP

Higher BP and CP in the supplemented group Sample size, race
Walz et al., 2020 Australia Cohort prospective 31 287 Oocyte collection day <20 ng/mL; ≥20ng/mL

CP

LB

FR

Blastocyst formation rate

Miscarriage

No correlation between clinical pregnancy and live births Sample, exogenous VD use, group follow-up
Doryanizadeh, 2020 Iran Clinical trial 26 95 4 weeks before embryo transfer <30ng/mL

BP

CP

OP

Miscarriage

Larger number of BPs in the VD-exposed group, but no differences in terms of CP and OP Dropouts during the study, season of the year, small sample size
Somigliana, 2021 Italy Clinical trial 24 360 2 to 12 weeks before IVF ≥30 ng/mL

CP

FR

IR

LB

Miscarriage

No differences Sample, safety study

The Newcastle-Ottawa scale was used to assess the quality of the cohort studies (Table 2). The clinical trial studies were randomized and double-blind.

Table 2.

Newcastle-Ottawa scale

Selection Comparability Outcome
Studies Representativity Unexposed cohort selection Ascertainment of exposure Outcome not present initially Comparability (confouding factors) Outcome assessment Follow-up duration Adequacy of follow-up Total
Rudick, 2012 * * * * ** * * * 9
Garbedian, 2013 * * * * ** * * * 9
Fabris, 2014 * * * * * * * * 8
Firouzabadi, 2014 * * * * * * * * 8
Paffoni, 2014 * * * * ** * * * 9
Polyzos, 2014 * * * * ** * * * 9
Rudick, 2014 * * * * ** * * * 9
Franasiak, 2015 * * * * ** * * * 9
Trably, 2015 * * * * * * * * 8
Neville, 2016 * * * * * * * 7
van de Vijver, 2016 * * * * ** * * * 9
Banker, 2017 * * * * * * * * 8
Fabris, 2017 * * * ** * * * 8
Ciepiela, 2018 * * * * * * * * 8
Wu, 2018 * * * * ** * 7
Walz, 2020 * * * * * * * * 8

Pregnancy outcome

In 5 articles, clinical pregnancy correlated positively with VD, and the highest rates of pregnancy were found in the group with the highest VD levels [13–17]. No such correlation was found in 10 articles [18–27], and in 1 article, the correlation was negative [28]. One article showed an improved biochemical and clinical pregnancy rate after VD supplementation [29]. The other two studies found no improvement in those pregnancy outcomes after VD intake [30, 31].

The reviewed articles assessed the IVF outcome considering the biochemical pregnancy rate (8 articles), the clinical pregnancy rate (14 articles), and the ongoing pregnancy rate (7 articles). The articles differed as to the definitions of clinical pregnancy and ongoing pregnancy. Four articles (29%) considered the visualization of the gestational sac on ultrasound a clinical pregnancy, whereas 9 articles (64%) also considered a fetal/embryonic heartbeat. In 1 article, the two detections were deemed necessary to define a clinical pregnancy. The articles considered embryos with heartbeats an ongoing pregnancy, but they differed as to when to verify the presence of heartbeats (at gestational weeks 6,7, or 12).

In the Rudick et al. (2012) study, in which 188 women participated, patients were categorized by race/ethnicity as non-Hispanic white (53%), Asian (26%), Hispanic white (14%), or other (7%) as well as VD levels. A lower clinical pregnancy rate was found in the VD-deficient group of non-Hispanic White women (deficiency—19%–n=3 vs insufficiency—44%–n=17 vs sufficiency—51%–n=23, p<0.04). This association was found to be inverse among Asian women (deficiency—64%–n=7 vs insufficiency—39%–n=7 vs sufficiency—15%–n=3, p=0.01). Although other studies also evaluated the patient’s race [13–17, 20–22, 27, 28], the VD status was not analyzed separately among race groups.

Ciepiela et al. (2018), in a study with 198 women, demonstrated the existence of a negative association between serum VD levels and IVF results. They showed that lower follicular VD values were associated with better embryos and higher biochemical and clinical pregnancy rates and live births, while the group with deficient serum VD levels had a higher rate of live births (OR = 1.09 (95% CI, 1.04–1.15) (p = 0.01).

Most of the studies under analysis, however, found that the different levels of VD did not correlate with the IVF results. Franasiak et al. (2015) conducted a study with IVF euploid embryos alone and did not find an association between VD levels and clinical pregnancy, biochemical pregnancy, or ongoing pregnancy. Considering only frozen embryo transfers, van de Vijver et al. (2016), in a study with 280 women, also found no association between VD and clinical pregnancy.

All clinical trials included only VD-deficient subjects. Abedi et al. (2019) found an improved biochemical and clinical pregnancy among women supplemented with 50,000U weekly for 6 weeks (compared with a placebo). Doryanizadeh et al. (2020) detected a higher biochemical pregnancy rate in the group supplemented with calcitriol 0.25 mcg for 4 weeks than in the control group. However, such a difference was not maintained when contrasting the clinical pregnancy rate and the ongoing pregnancy rate. Another clinical trial that was conducted by Somigliana et al. (2021) also found no significant difference between the group that took a single oral dose of 600,000 U of VD and the placebo group in terms of clinical pregnancy.

Live births

Eight of the articles assessed live birth rates. Three of them [13, 16, 17] found that the group of nondeficient VD women had a higher live birth rate, while 4 [23, 24, 27, 28] found no statistically significant differences between the groups with VD deficiency and those with no VD deficiency. One article detected no difference between the group of VD-deficient women who used VD and the control group that used a placebo [31].

Miscarriage

In nine articles, the miscarriage rate was assessed. One study showed a higher miscarriage rate in the VD-deficient group [28]. Six of the articles found no statistical differences between the miscarriage rate and VD levels [18, 20, 21, 24, 26, 27]. The two clinical trials found no difference in the miscarriage rate of VD-deficient patients (levels under 30 ng/mL) treated with oral VD [30, 31].

Egg donation

Four articles assessed the connection between VD and IVF results within the context of egg donation. Three of the articles [18, 24, 25] found no difference between the pregnancy rate and the donor’s or recipient’s VD levels, while 1 article [17] detected worse pregnancy rates in recipients with VD levels lower than 30 ng/mL.

Cellular immunity

Wu et al. (2018) studied the markers of cellular immunity and their association with VD and IVF results. In the VD-deficient group, they found a greater number of natural killer (NK) cells, B cells, and a higher proportion of T helper/T cytotoxic (Th/Tc) cells, as well as an association with a lower number of mature oocytes. The miscarriage rate was also higher in the group with VD deficiency, and the live birth rate was smaller, but these findings had no statistical significance.

Vitamin D measurements

All articles measured the serum 25-hydroxyvitamin D (25(OH)D) concentration, and 3 articles [19, 26, 28] measured 25(OH)D in the follicular fluid as well. A positive correlation was established between serum and follicular fluid measurements in all 3 articles. Two articles also assessed the bioavailable VD (or free VD) [18, 25], and their results were similar to those found for 25(OH)D.

Discussion

Vitamin D has a wide range of actions in the body. In the reproductive system, it has been recognized in different organs and tissues, such as the ovaries, endometrium, placenta, and testicles. Its action and influence mechanisms may not be completely understood, yet studies have demonstrated that VD action involves the stimulation of estrogen production in the ovarian tissue and that its receptor gene expression is higher in rat endometrium in the estrogen phase of the menstrual cycle, which gives rise to questions about its role in the reproductive functions. In the present review, it was not possible to establish a correlation between VD levels and IVF results.

In the present review as well, 16 cohort studies and 3 clinical trials were analyzed; most did not find an association between VD and IVF outcomes, 6 found a positive association, and 1, a negative association. VD intake improved biochemical and clinical pregnancy in one clinical trial but not in the other two. The included clinical trials presented different supplementation schemes regarding the dosage and duration of oral VD. There were also different pre-treatment VD serum levels among the studies, which raises the question if women with lower VD levels could benefit from treatment. The wide heterogeneity of the articles and study populations, along with the disparity of the findings, especially in relation to the pregnancy rates, hindered the analysis of the results.

Rudick et al. (2012) found that the link between VD and IVF outcomes differed significantly according to race (non-Hispanic White women vs Asian women), raising the possibility that the racial issue is an important factor to consider when assessing serum VD levels.

Chu et al. (2017) in a meta-analysis of 11 cohort studies found a higher likelihood of clinical pregnancy in the group with VD sufficiency (OR= 1.46 (95% CI, 1.05–2.02) than in the groups with VD deficiency and insufficiency, as well as a higher rate of live births (7 studies) in the same group (OR=1.33 (95% CI, 1.08–1.65) [32]. In a systematic review with a meta-analysis, Zhao et al. (2018) analyzed 9 cohort studies and found no difference between the clinical and the ongoing pregnancies among the groups with and without VD deficiency and found a lower live birth rate in the VD-deficient group (RR = 0.72 (95% CI, 0.58, 0.90) (p = 0.004). The latter finding was based on only 3 studies; there are more recent studies that have not found a connection between the two variables [24, 27, 30, 33]. Likewise, even more recently, Shen et al. (2019), in a meta-analysis comprising 5 cohort studies, found no association between clinical pregnancy and VD levels, notwithstanding a tendency towards worse IVF results in the group with VD deficiency [34]. It should be emphasized that, despite the meta-analyses comprising these studies, their great differences in population and treatment protocols, together with the dissimilar definitions for the outcomes, render the results of these meta-analyses unreliable.

The association between live birth rate and VD was analyzed by 7 cohort studies and 1 clinical trial. Five of these studies were not included in previous systematic reviews because they were published only recently. Van de Vijver et al. (2016), in a study with 280 women, found no significant difference in live births between the groups with and without VD deficiency. Wu et al. (2018) found a higher proportion of live births in the nondeficient-VD group (18/20–90% vs. 19/24–79.2%), but it was not statistically significant. Nor was it in a study conducted by Walz et al. (2020); however, given the time lapse between VD measurements and the outcome in some cases, their analysis could be biased. On the other hand, in a study with 198 women, Ciepiela et al. (2018) performed a logistic regression analysis that showed a VD deficiency relating to a higher live birth rate (OR = 1.09 (95% CI, 1.04–1.15) (p = 0.01). In a study conducted by Somigliana et al. (2021) with 630 women, no increase in the live birth rate was found after the VD-deficient women took supplements of the vitamin.

It is important to discuss this topic to better understand the factors associated with infertility. Clarity could help improve post-IVF results or aid in the identification of subgroups who could benefit from VD replacement.

The study carried out by Wu et al. (2018) considers that it might be possible that immune factors related to IVF outcomes are mediated by VD. This raises interesting questions, related primarily to cellular immunity and its role in assisted reproduction.

One of the strengths of this review is the fact that it was conducted using a variety of databases, which diminishes the risk of a publication bias. Also, the quality of the studies is good, as assessed by the Newcastle-Ottawa scale and new studies published on the subject were included. The limitations of this systematic review are mainly caused by the wide heterogeneity of the studies with respect not only to study design, but also to population characteristics (race, age, causes of infertility), the reference values used for considering VD deficiency, and the number of women included in some of the studies. Furthermore, the heterogeneity of the definitions of clinical pregnancy and ongoing pregnancy among the studies hindered a final assessment of the results.

Some open questions about the role of VD in IVF treatment are the role of race/ethnicity regarding IVF results and if the treatment with oral VD could improve IVF results. New studies are necessary on those issues and bigger clinical trials evaluating if VD intake could improve IVF outcomes and what groups of patients could benefit from that.

Conclusion

The association between serum VD levels and post-IVF pregnancy rate is still uncertain. However, VD levels would be more relevant in the white than in the Asian ethnicity and in the number of aspiration follicles, and they could act in the immune system having an impact both on embryo implantation and on pregnancy. There is a need for more high-quality clinical trials to answer the question if VD supplementation could improve IVF outcomes.

Declarations

The authors have no competing interests to declare that are relevant to the content of this article. The authors did not receive support from any organization for the submitted work.

Author contributions

Dani Ejzenberg had the idea for the article. All authors contributed to the study conception and design. Ana Berquó Peleja Eller and Dani Ejzenberg performed the literature search. The first draft of the manuscript was written by Ana Berquó Peleja Eller, and all authors commented on previous versions of the manuscript. The work was critically revised by José Maria Soares Jr. The authors read and approved the final manuscript.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary reference intakes for calcium and vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Washington (DC): National Academies Press (US); 2011. [PubMed] [Google Scholar]
  • 2.Fung JL, Hartman TJ, Schleicher RL, Goldman MB. Association of vitamin D intake and serum levels with fertility: results from the Lifestyle and Fertility Study. Fertil Steril. 2017;108(2):302. doi: 10.1016/j.fertnstert.2017.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Shahbazi M, Jeddi-Tehrani M, Zareie M, Salek-Moghaddam A, Akhondi MM, Bahmanpoor M, Sadeghi MR, Zarnani AH. Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice. Placenta. 2011;32(9):657. doi: 10.1016/j.placenta.2011.06.013. [DOI] [PubMed] [Google Scholar]
  • 4.Zarnani AH, Shahbazi M, Salek-Moghaddam A, Zareie M, Tavakoli M, Ghasemi J, Rezania S, Moravej A, Torkabadi E, Rabbani H, Jeddi-Tehrani M. Vitamin D3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle. Fertil Steril. 2010;93(8):2738. doi: 10.1016/j.fertnstert.2009.09.045. [DOI] [PubMed] [Google Scholar]
  • 5.Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, Seto-Young D. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res. 2010;42(10):754. doi: 10.1055/s-0030-1262837. [DOI] [PubMed] [Google Scholar]
  • 6.Blomberg Jensen M, Nielsen JE, Jørgensen A, Rajpert-De Meyts E, Kristensen DM, Jørgensen N, Skakkebaek NE, Juul A, Leffers H. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25(5):1303. doi: 10.1093/humrep/deq024. [DOI] [PubMed] [Google Scholar]
  • 7.Walters MR. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty. Endocrinology. 1984;114(6):2167. doi: 10.1210/endo-114-6-2167. [DOI] [PubMed] [Google Scholar]
  • 8.Halloran BP, DeLuca HF. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr. 1980;110(8):1573. doi: 10.1093/jn/110.8.1573. [DOI] [PubMed] [Google Scholar]
  • 9.Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141(4):1317. doi: 10.1210/endo.141.4.7403. [DOI] [PubMed] [Google Scholar]
  • 10.Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391. doi: 10.1038/ng0897-391. [DOI] [PubMed] [Google Scholar]
  • 11.Galvão TF, Pansani TSA, Harrad D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde. 2015;24:335. doi: 10.5123/S1679-49742015000200017. [DOI] [Google Scholar]
  • 12.Ministério da Saúde. Diretrizes metodológicas: elaboração de revisão sistemática e metanálise de estudos observacionais comparativos sobre fatores de risco e prognóstico. 2014. https://www.gov.br/conitec/pt-br/midias/artigos_publicacoes/diretrizes/estudosobservacionais.pdf. Accessed 19 Dec 2021.
  • 13.Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod. 2012;27(11):3321. doi: 10.1093/humrep/des280. [DOI] [PubMed] [Google Scholar]
  • 14.Garbedian K, Boggild M, Moody J, Liu KE. Effect of vitamin D status on clinical pregnancy rates following in vitro fertilization. CMAJ Open. 2013;1(2):E77. doi: 10.9778/cmajo.20120032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Paffoni A, Ferrari S, Viganò P, Pagliardini L, Papaleo E, Candiani M, Tirelli A, Fedele L, Somigliana E. Vitamin D deficiency and infertility: insights from in vitro fertilization cycles. J Clin Endocrinol Metab. 2014;99(11):E2372. doi: 10.1210/jc.2014-1802. [DOI] [PubMed] [Google Scholar]
  • 16.Polyzos NP, Anckaert E, Guzman L, Schiettecatte J, Van Landuyt L, Camus M, Smitz J, Tournaye H. Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI. Hum Reprod. 2014;29(9):2032. doi: 10.1093/humrep/deu156. [DOI] [PubMed] [Google Scholar]
  • 17.Rudick BJ, Ingles SA, Chung K, Stanczyk FZ, Paulson RJ, Bendikson KA. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil Steril. 2014;101(2):447. doi: 10.1016/j.fertnstert.2013.10.008. [DOI] [PubMed] [Google Scholar]
  • 18.Fabris A, Pacheco A, Cruz M, Puente JM, Fatemi H, Garcia-Velasco JA. Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril. 2014;102(6):1608. doi: 10.1016/j.fertnstert.2014.08.030. [DOI] [PubMed] [Google Scholar]
  • 19.Firouzabadi RD, Rahmani E, Rahsepar M, Firouzabadi MM. Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program. Arch Gynecol Obstet. 2014;289:201. doi: 10.1007/s00404-013-2959-9. [DOI] [PubMed] [Google Scholar]
  • 20.Franasiak JM, Molinaro TA, Dubell EK, Scott KL, Ruiz AR, Forman EJ, Werner MD, Hong KH, Scott RT., Jr Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts. Am J Obstet Gynecol. 2015;212(3):315. doi: 10.1016/j.ajog.2014.09.029. [DOI] [PubMed] [Google Scholar]
  • 21.Trably C, Brosse A, Plotton I, Berthillier J, Du Mesnildot P, Hadj S, Lornage J, Salle B. Valeur prédictive du dosage de vitamine D sur les taux de grossesse dans une cohorte de patientes suivies en FIV [Predictive value of vitamin D plasma levels on pregnancy rates in a cohort of IVF patients] Gynecol Obstet Fertil. 2015;43(11):722. doi: 10.1016/j.gyobfe.2015.09.003. [DOI] [PubMed] [Google Scholar]
  • 22.Neville G, Martyn F, Kilbane M, O'Riordan M, Wingfield M, McKenna M, McAuliffe FM. Vitamin D status and fertility outcomes during winter among couples undergoing in vitro fertilization/intracytoplasmic sperm injection. Int J Gynaecol Obstet. 2016;135(2):172. doi: 10.1016/j.ijgo.2016.04.018. [DOI] [PubMed] [Google Scholar]
  • 23.van de Vijver A, Drakopoulos P, Van Landuyt L, Vaiarelli A, Blockeel C, Santos-Ribeiro S, Tournaye H, Polyzos NP. Vitamin D deficiency and pregnancy rates following frozen-thawed embryo transfer: a prospective cohort study. Hum Reprod. 2016;31(8):1749. doi: 10.1093/humrep/dew107. [DOI] [PubMed] [Google Scholar]
  • 24.Banker M, Sorathiya D, Shah S. Vitamin D deficiency does not influence reproductive outcomes of IVF-ICSI: a study of oocyte donors and recipients. J Hum Reprod Sci. 2017;10(2):79. doi: 10.4103/jhrs.JHRS_117_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fabris AM, Cruz M, Iglesias C, Pacheco A, Patel A, Patel J, Fatemi H, García-Velasco JA. Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors. Reprod Biomed Online. 2017;35(2):139. doi: 10.1016/j.rbmo.2017.05.009. [DOI] [PubMed] [Google Scholar]
  • 26.Wu L, Kwak-Kim J, Zhang R, et al. Vitamin D level affects IVF outcome partially mediated via Th/Tc cell ratio. Am J Reprod Immunol. 2018;80(6):e13050. doi: 10.1111/aji.13050. [DOI] [PubMed] [Google Scholar]
  • 27.Walz NL, Hinchliffe PM, Soares MJ, Dhaliwal SS, Newsholme P, Yovich JL, Keane KN. Serum Vitamin D status is associated with increased blastocyst development rate in women undergoing IVF. Reprod Biomed Online. 2020;41(6):1101. doi: 10.1016/j.rbmo.2020.08.014. [DOI] [PubMed] [Google Scholar]
  • 28.Ciepiela P, Dulęba AJ, Kowaleczko E, Chełstowski K, Kurzawa R. Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome. J Assist Reprod Genet. 2018;35:1265. doi: 10.1007/s10815-018-1179-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abedi S, Taebi M, Nasr Esfahani MH. Effect of vitamin D supplementation on intracytoplasmic sperm injection outcomes: a randomized double-blind placebo-controlled trial. Int. J Fertil Steril. 2019;13(1):18. doi: 10.22074/ijfs.2019.5470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Doryanizadeh L, Morshed-Behbahani B, Parsanezhad ME, Dabbaghmanesh MH, Jokar A. Calcitriol effect on outcomes of in vitro fertilization in infertile women with vitamin D deficiency: a double-blind randomized clinical trial. Z Geburtshilfe Neonatol. 2021;225(3):226. doi: 10.1055/a-1206-1064. [DOI] [PubMed] [Google Scholar]
  • 31.Somigliana E, Sarais V, Reschini M, Ferrari S, Makieva S, Cermisoni GC, Paffoni A, Papaleo E, Vigano P. Single oral dose of vitamin D3 supplementation prior to in vitro fertilization and embryo transfer in normal weight women: the SUNDRO randomized controlled trial. Am J Obstet Gynecol. 2021;225(3):283. doi: 10.1016/j.ajog.2021.04.234. [DOI] [PubMed] [Google Scholar]
  • 32.Chu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod. 2018;33(1):65. doi: 10.1093/humrep/dex326. [DOI] [PubMed] [Google Scholar]
  • 33.Zhao J, Huang X, Xu B, Yan Y, Zhang Q, Li Y. Whether vitamin D was associated with clinical outcome after IVF/ICSI: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16:1–7. doi: 10.1186/s12958-018-0324-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Shen C, Wang L, Wu X, Mao S, Fang C. The relationship between vitamin D and IVF: a systematic review and meta-analysis. Clin. Exp. Obstet. Gynecol. 2019;46(1):12. doi: 10.12891/ceog4117.2019. [DOI] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer

RESOURCES